p38α MAPK is required for arsenic-induced cell transformation

Area of Science:

• Environmental Toxicology
• Molecular Biology
• Cellular Transformation

Background:

• Arsenic exposure is linked to neoplastic transformation.
• Polycomb group (PcG) proteins are implicated in arsenic-induced cancer.
• The specific molecular pathways mediating arsenic's effects require further elucidation.

Purpose of the Study:

• To investigate the role of p38α mitogen-activated protein kinase (MAPK) in arsenic-induced neoplastic transformation.
• To elucidate the downstream signaling events, including CREB phosphorylation and AP-1 activation, involved in this process.

Main Methods:

• BALB/c 3T3 cells were exposed to arsenic (0.5 μM).
• Assessed CRE and c-Fos promoter activities, CREB phosphorylation, and AP-1 activation.
• Utilized short hairpin (sh) RNA targeting p38α to knockdown its expression.
• Investigated the effects of p38 inhibition on arsenic-induced cellular responses.

Main Results:

• Arsenic exposure increased CRE and c-Fos promoter activities, CREB phosphorylation, and AP-1 activation.
• Knockdown of p38α significantly suppressed arsenic-induced colony formation.
• p38α knockdown attenuated CREB phosphorylation and AP-1 activation following arsenic treatment.
• Pharmacological inhibition of p38 reduced arsenic-induced AP-1 activation and CREB phosphorylation.

Conclusions:

• p38α MAPK activation is essential for arsenic-induced neoplastic transformation.
• The mechanism involves the modulation of CREB phosphorylation and AP-1 activation.
• Targeting the p38α MAPK pathway may offer strategies to mitigate arsenic-induced carcinogenesis.